Product Program year 2025 Source: CMS Open Payments

Gozellix

Drug Prostate Cancer Diagnosis

Open in the dashboard

General payments

$9,198

20 payments

Research payments

$0

0 payments

Through program year 2025, $9,198 in general payments and $0 in research payments were reported against Gozellix (Prostate Cancer Diagnosis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $9,198 20

Breakdown

Who paid General payments · program year 2025
  1. Telix Pharmaceuticals $9,198 20 payments
Top recipients General payments · program year 2025
  1. Jaideep Sohi Nuclear Radiology · Roseville, CA $7,200 78% · 2 payments
  2. Scott Tagawa Hematology & Oncology · New York, NY $229 2% · 2 payments
  3. Ming Yang Diagnostic Radiology · Scottsdale, AZ $129 1% · 1 payment
  4. Matthew Brady Diagnostic Radiology · Charleston, SC $129 1% · 1 payment
  5. Hemet Kherbache Nuclear Imaging & Therapy · Annandale, VA $129 1% · 1 payment

The top 5 of 18 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nuclear Radiology Radiology $7,200 79% · 1 practitioner
  2. Diagnostic Radiology Radiology $615 7% · 5 practitioners
  3. Urology $499 5% · 5 practitioners
  4. Nuclear Imaging & Therapy Nuclear Medicine $258 3% · 2 practitioners
  5. Hematology & Oncology Internal Medicine $229 3% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $7,329 80% · 2 recipients
  2. New York $885 10% · 7 recipients
  3. Arizona $229 2% · 2 recipients
  4. Idaho $199 2% · 2 recipients
  5. South Carolina $129 1% · 1 recipient

The top 5 of 9 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

20 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record